Follow the guidance [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2021-08-27 12:31 (521 d 19:48 ago) – Posting: # 22549
Views: 1,242

Hi Suchit,

❝ As per latest published draft guideline "Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA" […] one sentence is there like The concentration data for the subject who vomited should be reported


❝ Hence it is required to report concentration data of subject who had vomited for the USFDA studies


Correct.

❝ Valuable suggestions required


Suggestions about what? Simply follow the guidance.

BTW, in my CRO we always analyzed all samples.*
Justification: Although subjects who vomited (IR \(\small{\leq 2\times\widetilde{t_\textrm{max,R}}}\) and MR \(\small{\leq\tau}\)) were excluded from the comparison according to the protocol, their profile was informative. It’s always good to learn something. It turned out that – surprisingly more often than not – the effect was a minor one.



Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,477 posts in 4,708 threads, 1,603 registered users;
11 visitors (0 registered, 11 guests [including 4 identified bots]).
Forum time: 07:20 CET (Europe/Vienna)

The mediocre teacher tells.
The good teacher explains.
The superior teacher demonstrates.
The great teacher inspires.    William Arthur Ward

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5